Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · IEX Real-Time Price · USD
18.64
-0.19 (-1.01%)
At close: Jul 19, 2024, 4:00 PM
18.58
-0.06 (-0.32%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Phibro Animal Health Revenue

Phibro Animal Health had revenue of $999.56M in the twelve months ending March 31, 2024, with 2.19% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $263.22M with 7.14% year-over-year growth. In the fiscal year ending June 30, 2023, Phibro Animal Health had annual revenue of $977.89M with 3.78% growth.

Revenue (ttm)
$999.56M
Revenue Growth
+2.19%
P/S Ratio
0.76
Revenue / Employee
$520,606
Employees
1,920
Market Cap
754.99M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 2023977.89M35.63M3.78%
Jun 30, 2022942.26M108.91M13.07%
Jun 30, 2021833.35M33.00M4.12%
Jun 30, 2020800.35M-27.64M-3.34%
Jun 30, 2019828.00M8.01M0.98%
Jun 30, 2018819.98M55.70M7.29%
Jun 30, 2017764.28M12.76M1.70%
Jun 30, 2016751.53M2.94M0.39%
Jun 30, 2015748.59M56.68M8.19%
Jun 30, 2014691.91M38.76M5.93%
Jun 30, 2013653.15M-950.00K-0.15%
Jun 30, 2012654.10M35.77M5.78%
Jun 30, 2011618.33M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Embecta 1.13B
Evolus 219.70M
Travere Therapeutics 183.23M
OrthoPediatrics 161.83M
4D Molecular Therapeutics 20.45M
Abivax 5.13M
Dianthus Therapeutics 2.26M
Pliant Therapeutics 248.00K
Revenue Rankings